Globeflex Capital L P Invests $1.29 Million in Cardinal Health, Inc. $CAH

Globeflex Capital L P purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 5,420 shares of the company’s stock, valued at approximately $1,288,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Matters Capital LLC acquired a new stake in shares of Cardinal Health in the second quarter valued at about $251,000. Clear Harbor Asset Management LLC acquired a new position in Cardinal Health during the second quarter valued at approximately $772,000. First Nebraska Trust Co acquired a new position in Cardinal Health during the second quarter valued at approximately $20,050,000. Bank of Nova Scotia bought a new position in Cardinal Health in the second quarter valued at approximately $88,870,000. Finally, Kendall Capital Management bought a new position in Cardinal Health in the second quarter valued at approximately $379,000. 87.17% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Leerink Partners set a $292.00 price objective on Cardinal Health in a research report on Tuesday, August 11th. Morgan Stanley lifted their price objective on shares of Cardinal Health from $255.00 to $265.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Barclays increased their price objective on shares of Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, August 13th. TD Cowen raised their target price on shares of Cardinal Health from $275.00 to $280.00 and gave the stock a “buy” rating in a research note on Thursday, August 13th. Finally, William Blair assumed coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Sixteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $266.56.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health’s specialty business remains a key growth driver, supporting the case for retaining CAH in portfolios. The company has also issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, broadly consistent with analyst expectations. Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
• Positive Sentiment: Recent coverage highlights Cardinal Health’s efforts to expand its healthcare reach, potentially creating additional growth opportunities beyond its core pharmaceutical distribution operations. Why Is Cardinal Health Expanding Its Healthcare Reach?
• Positive Sentiment: Cardinal Health’s latest quarterly results provided support for the stock: earnings per share exceeded consensus estimates, while revenue increased year over year. The company’s medical and pharmaceutical services also remain central to its relative performance within the healthcare providers and services group. Winners and Losers of Q2: Cardinal Health vs. Healthcare Providers and Services Stocks

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 80,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.74, for a total transaction of $18,859,200.00. Following the completion of the transaction, the chief executive officer owned 235,132 shares in the company, valued at approximately $55,430,017.68. This trade represents a 25.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Deborah Weitzman sold 7,354 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the completion of the transaction, the chief executive officer owned 77,901 shares in the company, valued at approximately $18,341,790.45. The trade was a 8.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 210,271 shares of company stock valued at $49,626,657 over the last ninety days. Insiders own 0.12% of the company’s stock.

Cardinal Health Stock Up 1.1%

Shares of CAH stock opened at $232.13 on Tuesday. Cardinal Health, Inc. has a twelve month low of $145.87 and a twelve month high of $258.30. The company has a market cap of $53.99 billion, a P/E ratio of 32.11, a P/E/G ratio of 1.23 and a beta of 0.49. The business has a fifty day simple moving average of $232.13 and a 200 day simple moving average of $217.96.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. During the same period in the prior year, the company earned $2.08 EPS. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 12.54 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio is presently 28.49%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.